GlassScriptPhysician profile
Roger L Novack
NPI 1104828706
$5,350.78
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,064 · 2020: $67.64 · 2021: $48.89 · 2022: $171.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,127.92 | 2019 | |
| Alimera Sciences, INC. | $1,285.69 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $582.63 | 2019-2020 | |
| Dutch Ophthalmic, USA | $500.00 | 2019 | |
| Alcon Vision LLC | $270.07 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $206.15 | 2019 | |
| Bausch & Lomb Americas INC. | $122.90 | 2022 | |
| Genentech USA, INC. | $108.66 | 2019-2022 | |
| Genentech, INC. | $77.49 | 2019 | |
| Beaver-Visitec International, INC. | $33.23 | 2019 | |
| Allergan, INC. | $18.53 | 2019 | |
| Glaxosmithkline, LLC. | $17.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Novack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.